Related Experiment Video
Updated: Jun 10, 2025

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
MRI-Based Multi-Class Relevance Vector Machine Classification of Neurodegenerative Diseases
Medrxiv : the Preprint Server for Health Sciences
|October 17, 2024
Summary
Machine learning accurately identifies dementia subtypes from MRI scans, though misclassification highlights disease complexity and imaging limitations. Improved datasets are crucial for enhancing diagnostic accuracy in neurodegenerative diseases.
Area of Science:
- Neuroimaging and computational neuroscience
- Neurology and neurodegenerative disease research
- Artificial intelligence in healthcare
Background:
- Machine learning (ML) shows promise for dementia diagnosis, yet misclassification in MRI-based studies remains a challenge.
- Understanding the drivers of misclassification is critical for advancing automated diagnostic tools.
- Existing ML approaches often struggle with the heterogeneity of neurodegenerative diseases.
Purpose of the Study:
- To implement and evaluate a multi-class classification approach using ML for diagnosing seven neurodegenerative conditions from T1-weighted MRI scans.
- To investigate the reasons behind misclassification by comparing ML predictions with clinical, pathological, genetic, and imaging data.
- To assess the diagnostic performance of ML across different dementia subtypes and controls.
Main Methods:
- Utilized a multi-class classification model employing relevance vector machine and logistic classification.
- Analyzed whole-brain T1-weighted MRI scans from 468 participants across seven diagnostic groups: healthy controls, Alzheimer's disease (AD), behavioral variant frontotemporal dementia (bvFTD), semantic variant primary progressive aphasia (svPPA), non-fluent variant primary progressive aphasia (nfvPPA), corticobasal syndrome (CBS), and progressive supranuclear palsy syndrome (PSPS).
- Validated diagnostic accuracy against clinical, pathological, genetic, and quantitative imaging data.
Main Results:
- The algorithm achieved 71% accuracy in predicting specific neurodegenerative syndromes, 80% for the disease spectrum, and 85% in distinguishing controls from any dementia.
- High performance was observed for healthy controls, moderate for AD, bvFTD, and svPPA, and low for CBS, nfvPPA, and PSPS.
- Misclassified cases often exhibited minimal atrophy and brain volumes similar to controls, particularly early-onset AD and bvFTD with specific genetic mutations or phenocopies.
Conclusions:
- Neurodegenerative disease heterogeneity and the limitations of structural MRI in capturing biological changes contribute to ML misclassification.
- Larger, more inclusive datasets reflecting population heterogeneity are necessary for training robust ML models.
- A degree of uncertainty and margin of error in automated diagnoses is expected and should be considered analogous to clinical diagnostic uncertainty.

